- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
June 3, 2013 (UI Hospital) — University of Iowa Hospital and Clinics is recruiting volunteers to participate in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. Beginning recruitment in June, the project is called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study.
June 2, 2013 (ADA) — The American Diabetes Association (Association) and Eli Lilly and Company (NYSE: LLY) are pleased to announce the creation of a three-year collaborative research program aimed at better understanding diabetes care in older adults, many of whom are disproportionately affected by this disease.
The program, "American Diabetes Association and Lilly Clinical Research Award: Diabetes Care in Older Adults," will grant a total of $1.2 million for targeted research awards and was
May 23, 2013 (Stanford School of Medicine) — Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.
The researchers reanalyzed disease data to demonstrate that the physiological pathways to diabetes vary between Africa and East Asia and that those differences are reflected in part by genetic differences. The studies published online simultaneously May 23 in
May 21, 2013 (Garvan Institute) — Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
The breakthrough study, conducted by Sean Humphrey and Professor David James from Sydney's Garvan Institute of Medical Research, is now published in the early online edition of the prestigious journal Cell Metabolism.<
May 29, 2013 (Newswise) — Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.